123 related articles for article (PubMed ID: 16475806)
1. The 108M polymorph of human catechol O-methyltransferase is prone to deformation at physiological temperatures.
Rutherford K; Bennion BJ; Parson WW; Daggett V
Biochemistry; 2006 Feb; 45(7):2178-88. PubMed ID: 16475806
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of human 108V and 108M catechol O-methyltransferase.
Rutherford K; Le Trong I; Stenkamp RE; Parson WW
J Mol Biol; 2008 Jun; 380(1):120-30. PubMed ID: 18486144
[TBL] [Abstract][Full Text] [Related]
3. The V108M mutation decreases the structural stability of catechol O-methyltransferase.
Rutherford K; Alphandéry E; McMillan A; Daggett V; Parson WW
Biochim Biophys Acta; 2008; 1784(7-8):1098-105. PubMed ID: 18474266
[TBL] [Abstract][Full Text] [Related]
4. Oxidative inhibition of human soluble catechol-O-methyltransferase.
Cotton NJ; Stoddard B; Parson WW
J Biol Chem; 2004 May; 279(22):23710-8. PubMed ID: 15031283
[TBL] [Abstract][Full Text] [Related]
5. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two new variants of human catechol O-methyltransferase in vitro.
Li Y; Yang X; van Breemen RB; Bolton JL
Cancer Lett; 2005 Dec; 230(1):81-9. PubMed ID: 16253764
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore modeling and virtual screening studies to design potential COMT inhibitors as new leads.
Jatana N; Sharma A; Latha N
J Mol Graph Model; 2013 Feb; 39():145-64. PubMed ID: 23280413
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of the apo and holo form of rat catechol-O-methyltransferase.
Tsuji E; Okazaki K; Isaji M; Takeda K
J Struct Biol; 2009 Mar; 165(3):133-9. PubMed ID: 19111934
[TBL] [Abstract][Full Text] [Related]
9. Design of electrochemical biosensor systems for the detection of specific DNA sequences in PCR-amplified nucleic acids related to the catechol-O-methyltransferase Val108/158Met polymorphism based on intrinsic guanine signal.
Ozkan-Ariksoysal D; Tezcanli B; Kosova B; Ozsoz M
Anal Chem; 2008 Feb; 80(3):588-96. PubMed ID: 18181582
[TBL] [Abstract][Full Text] [Related]
10. Functional and structural comparisons of cysteine residues in the Val108 wild type and Met108 variant of human soluble catechol O-methyltransferase.
Li Y; Yang X; Chang M; Yager JD; van Breemen RB; Bolton JL
Chem Biol Interact; 2005 Apr; 152(2-3):151-63. PubMed ID: 15840388
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-methyltransferase low activity genotype (COMTLL) is associated with low levels of COMT protein in human hepatocytes.
Doyle AE; Goodman JE; Silber PM; Yager JD
Cancer Lett; 2004 Oct; 214(2):189-95. PubMed ID: 15363545
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D
Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881
[TBL] [Abstract][Full Text] [Related]
13. A hotspot of inactivation: The A22S and V108M polymorphisms individually destabilize the active site structure of catechol O-methyltransferase.
Rutherford K; Daggett V
Biochemistry; 2009 Jul; 48(27):6450-60. PubMed ID: 19435324
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
[TBL] [Abstract][Full Text] [Related]
16. Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR.
Ruiz-Sanz JI; Aurrekoetxea I; Ruiz del Agua A; Ruiz-Larrea MB
Mol Cell Probes; 2007 Jun; 21(3):202-7. PubMed ID: 17337160
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.
Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F
Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606
[TBL] [Abstract][Full Text] [Related]
18. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis.
Pooley EC; Fineberg N; Harrison PJ
Mol Psychiatry; 2007 Jun; 12(6):556-61. PubMed ID: 17264842
[TBL] [Abstract][Full Text] [Related]
19. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated and non-phosphorylated forms of catechol O-methyltransferase in rat liver, brain and other tissues.
Øverbye A; Seglen PO
Biochem J; 2009 Jan; 417(2):535-45. PubMed ID: 18831714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
